Interesting, appears in basically every local paper but no notice to the ASX: Reading The Australian coverage, it appears it's an allocation of grant funds from the existing $5m grant:
"The Federal Government invested $5 million in April last year for the 12 month trial to promote innovation in the sector and support improved care and pain assessment for people living with dementia or other cognitive impairments.
Of that, $3 million has already been spent and a further $2 million has been allocated for the six month extension"
This seems to contradict that other sources that suggestion it as 'additional' funds.
PCK Price at posting:
8.9¢ Sentiment: Buy Disclosure: Held
